$IBIO OWS actively engaged with manufactures HHS helped build in recent years. Without a doubt iBio is a part of those negotiations, we’re waiting on preclinical results before anything else. We already know they’re showing promise and we know they’ll get funding for mass production when it reaches human trials. (Dr Parker’s words)
  • 5